The silver amplification immunochromatography-based test kits detect SARS-CoV-2 antigens using nasopharyngeal swab samples. Credit: © FUJIFILM Corporation.

Fujifilm Europe has launched its rapid antigen test kit for the detection of SARS-CoV-2 infection, following the receipt of the CE certificate.

The company is using its silver amplification immunochromatography method based on silver halide amplification technology.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

A highly sensitive antigen test is viable, even with SARS-CoV-2 antigen, by applying silver amplification immunochromatography, Fujifilm confirmed.

The antigen test kit is capable of examining the SARS-CoV-2 antigen’s presence in specimens rapidly, detecting the virus at an early stage.

The test kit uses nasopharyngeal swab samples and provides results within ten to 13 minutes.

It can also be used in community or clinical settings and provides quick results compared to the current laboratory tests.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

FUJIFILM Europe medical systems division senior vice-president Masaharu Fukumoto said: “During the pandemic, Fujifilm supported the global healthcare community in the complex management of the emergency.

“Today we can provide further support for the early detection of Covid-19, through a rapid antigen test that can provide a highly sensitive result for early detection.

“We used our proprietary silver amplification immunochromatographic method, that amplifies signal particles more than 100 times and increases the sensitivity, and has the potential to enhance detection in more asymptomatic patients carrying the Covid-19 virus an at an early stage.”

The company has marketed silver amplification immunochromatography-based rapid diagnostic testing equipment and reagents to detect influenza and other infectious diseases since 2011.

Additionally, it is contributing to the improvement in SARS-CoV-2 testing by supplying PCR test reagents and the reagents for use with the fully automated immunoassay system μTASWako g1.